ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

Date: Friday, November 6, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM
Abstract Number: 0090
110 Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Rheumatology Disease Unit: Fracture, Neuropathy, and Pernicious Anemia Are Clues to Recognition
9:00AM-11:00AM
Abstract Number: 0079
Analysis of COVID-19 and Rheumatology Twitter Activity During the Pandemic Months
9:00AM-11:00AM
Abstract Number: 0098
CCL2 and CCR2 in Adult Onset Still’s Disease
9:00AM-11:00AM
Abstract Number: 0083
Chronic Nonbacterial Osteomyelitis Is Associated with HLA-B*27
9:00AM-11:00AM
Abstract Number: 0085
Classifications of Inflammatory Myopathies: Differentially Expressed Membrane-Bound Complement Regulators Allow Specific Patterns of Membrane Attack Complex Deposition
9:00AM-11:00AM
Abstract Number: 0084
Clinical Characteristics of Patients with Rheumatism of Juvenile Onset and Adult Onset in the BIOBADAGUAY Cohort
9:00AM-11:00AM
Abstract Number: 0100
Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 0092
Diagnosis of Behçet’s Disease: Comparison of Two Sets of Classification Criteria. Application in 111 Patients of a Well-defined Population
9:00AM-11:00AM
Abstract Number: 0082
Diffuse Sclerosing Osteomyelitis of the Jaw: An Underdiagnosed Disease in Maxillofacial Surgery Department
9:00AM-11:00AM
Abstract Number: 0097
Does Testing for SAA Is More Beneficial Than CRP for the Follow-up of Patients with FMF?
9:00AM-11:00AM
Abstract Number: 0086
Geographic Distribution of Eosinophilic Fasciitis Cases in Massachusetts and Associated Environmental Triggers
9:00AM-11:00AM
Abstract Number: 0091
Helicobacter Pylori Infection, Autoimmune Disease and Paraproteinemia Influence the Presentation of a Cohort of 150 Pernicious Anemia Patients Diagnosed in a Rheumatology Clinic
9:00AM-11:00AM
Abstract Number: 0087
Hemophagocytic Syndrome. Clinical Characteristics and Prognostic Factors of a Series of 30 Clinical Cases
9:00AM-11:00AM
Abstract Number: 0099
Interleukin 6 Concentration in Synovial Fluid of Patients with Different Types of Arthritis
9:00AM-11:00AM
Abstract Number: 0077
Mimickers of Immunoglobulin G4-Related Disease
9:00AM-11:00AM
Abstract Number: 0081
Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome
9:00AM-11:00AM
Abstract Number: 0078
Retrospective Analysis of Clinical Characteristics and Classification Criteria Performance in a Single Center Cohort of 114 Patients Diagnosed with IgG4-Related Disease
9:00AM-11:00AM
Abstract Number: 0093
Review of Gastrointestinal Manifestations of Kohlmeier-Degos Disease
9:00AM-11:00AM
Abstract Number: 0095
Systematic Evaluation of Nine Monogenic Autoinflammatory Diseases Reveals Common and Disease-Specific Correlations with Allergy-Associated Features
9:00AM-11:00AM
Abstract Number: 0096
The Bicipital Stress Test: A Maneuver to More Accurately Diagnose Bicipital Tendinitis and Its Referred Pain Patterns
9:00AM-11:00AM
Abstract Number: 0089
The Risk Factors of Recurrence in Relapsing Polychondritis; A Study of 41 Cases
9:00AM-11:00AM
Abstract Number: 0088
The Spectrum of Hemophagocytic Lymphohistiocytosis: Autoimmunity vs. Malignancy
9:00AM-11:00AM
Abstract Number: 0080
Understanding Ankylosing Spondylitis –
9:00AM-11:00AM
Abstract Number: 0094
Validation Study of Proposed Diagnostic Criteria for Sympathetic Joint Effusion

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology